Literature DB >> 8150352

Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area.

B Ostenstad1, T Lea, E Schlichting, M Harboe.   

Abstract

This study investigated the phenotype of freshly isolated human tumour infiltrating lymphocytes (TIL) from 14 patients with colorectal tumours, and compared them with lymphocytes derived from the lamina propria of the unaffected mucosa and with lymphocytes derived from peripheral blood of the same patients. It was found that TIL expressed the activation markers CD25 and HLA-DR to a higher extent than the peripheral blood lymphocytes (p = 0.01), and that both lamina propria lymphocytes and TIL preferentially expressed the CD45RO + phenotype, associated with memory cells, in contrast with peripheral blood lymphocytes [corrected]. Both lamina propria lymphocytes and TIL contained few natural killer (NK) cells (CD3-CD56+) compared with peripheral blood lymphocytes (p = 0.001), and this was reflected in the cytotoxicity assays. After 1 to 2 weeks in culture with interleukin-2 100 U/ml, lymphocytes from all three compartments had a high cytolytic activity against all targets tested, consistent with the lymphokine activated killer cell phenomenon. No increase in the number of NK cells was noted after culture, but 20-30% of the T cells now coexpressed the CD56 molecule. This was most prominent in the CD8+ subset, but lymphokine activated killer cell activity was found in both CD4+ and CD8+ subsets. Possible tumour escape mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150352      PMCID: PMC1374595          DOI: 10.1136/gut.35.3.382

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

1.  Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms.

Authors:  M Plebanski; M Saunders; S S Burtles; S Crowe; D C Hooper
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

2.  Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity.

Authors:  W H McBride; J D Thacker; S Comora; J S Economou; D Kelley; D Hogge; S M Dubinett; G J Dougherty
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

3.  Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.

Authors:  M C Pandolfino; C Viret; N Gervois; Y Guilloux; F Davodeau; E Diez; F Jotereau
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

4.  Oligoclonal T lymphocytes infiltrating human lung cancer tissues.

Authors:  I Yoshino; T Yano; Y Yoshikai; M Murata; K Sugimachi; G Kimura; K Nomoto
Journal:  Int J Cancer       Date:  1991-03-12       Impact factor: 7.396

5.  Signalling in human tumour infiltrating lymphocytes: the CD28 molecule is functional and is physically associated with the CD45R0 molecule.

Authors:  M R Zocchi; A Poggi; F Crosti; S Tongiani; C Rugarli
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

6.  The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Authors:  E Weidmann; T L Whiteside; R Giorda; R B Herberman; M Trucco
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

7.  Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

Authors:  P T Golumbek; A J Lazenby; H I Levitsky; L M Jaffee; H Karasuyama; M Baker; D M Pardoll
Journal:  Science       Date:  1991-11-01       Impact factor: 47.728

8.  Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis.

Authors:  Y Kubota; R E Petras; K A Easley; T W Bauer; R R Tubbs; V W Fazio
Journal:  Cancer       Date:  1992-12-01       Impact factor: 6.860

9.  Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.

Authors:  H Mizoguchi; J J O'Shea; D L Longo; C M Loeffler; D W McVicar; A C Ochoa
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

10.  Lifespan of human lymphocyte subsets defined by CD45 isoforms.

Authors:  C A Michie; A McLean; C Alcock; P C Beverley
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

View more
  11 in total

1.  Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ.

Authors:  Moritz Koch; Philipp Beckhove; Jan Op den Winkel; Daniel Autenrieth; Philipp Wagner; Daniel Nummer; Sebastian Specht; Dalibor Antolovic; Luis Galindo; Friedrich H Schmitz-Winnenthal; Volker Schirrmacher; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

2.  T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.

Authors:  W M Mulder; E Bloemena; M J Stukart; J A Kummer; J Wagstaff; R J Scheper
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

3.  Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.

Authors:  W J Bateman; I Donnellan; I A Fraser; L S Wong; A G Morris
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

4.  Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Authors:  S M Todryk; H Chong; R G Vile; H Pandha; N R Lemoine
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

5.  Dissection of spontaneous cytotoxicity by human intestinal intraepithelial lymphocytes: MIC on colon cancer triggers NKG2D-mediated lysis through Fas ligand.

Authors:  Ellen C Ebert; Veronika Groh
Journal:  Immunology       Date:  2008-02-13       Impact factor: 7.397

6.  Interleukin 21 up-regulates perforin-mediated cytotoxic activity of human intra-epithelial lymphocytes.

Authors:  Ellen C Ebert
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

7.  Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas.

Authors:  P A Jackson; M A Green; C G Marks; R J King; R Hubbard; M G Cook
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

8.  High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours.

Authors:  E Venetsanakos; I Beckman; J Bradley; J M Skinner
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  The immunogenicity of colorectal cancers with high-degree microsatellite instability.

Authors:  Ayan Banerjea; Stephen A Bustin; Sina Dorudi
Journal:  World J Surg Oncol       Date:  2005-05-12       Impact factor: 2.754

10.  Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours.

Authors:  B Ostenstad; M Sioud; T Lea; E Schlichting; M Harboe
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.